Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

2.2K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
2.2K
Autoimmune Disorders01:29

Autoimmune Disorders

2.0K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
2.0K
T Cell Types and Functions01:24

T Cell Types and Functions

2.8K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.8K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

17.2K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epstein-Barr virus and multiple sclerosis: from associations to mechanisms to potential therapies.

The Lancet. Neurology·2026
Same author

Proinflammatory Epstein-Barr Virus Antibody Functions Track with Disease Activity in Multiple Sclerosis.

Annals of neurology·2026
Same author

Monocyte-derived macrophages drive neurological tissue damage through mitochondrial reactive oxygen species.

Science immunology·2026
Same author

Not so cold after all: tumor infiltrating CD8+ T cells in EBV-positive Burkitt lymphoma are quiescent, not exhausted.

bioRxiv : the preprint server for biology·2026
Same author

Precision modeling of tumor antigen-specific T-cell responses in humanized mice for preclinical assessment of cancer immunotherapies.

Journal for immunotherapy of cancer·2026
Same author

Triggering multiple sclerosis: infection with Epstein-Barr virus activates multiple pre-existing autoreactive B and T cells.

Signal transduction and targeted therapy·2026

Related Experiment Video

Updated: Feb 24, 2026

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

4.7K

Latent, Lytic, and Linked to Multiple Sclerosis-How EBV Drives Autoimmunity.

Fabienne Läderach1, Elena Bremer2, Christian Münz2

  • 1Institute of Experimental Immunology, University of Zürich, Zürich, Switzerland.

European Journal of Immunology
|February 22, 2026
PubMed
Summary

Epstein-Barr virus (EBV) infection may drive B cells into the central nervous system, causing inflammation and contributing to multiple sclerosis (MS) in some patients. EBV-specific treatments could offer new therapeutic options for MS.

Keywords:
AutoimmunityB cellsCNSEpstein‐Barr virusMultiple‐Sclerosis

More Related Videos

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

9.7K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.9K

Related Experiment Videos

Last Updated: Feb 24, 2026

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
09:14

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line

Published on: September 28, 2022

4.7K
An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

9.7K
Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
09:38

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination

Published on: September 12, 2016

12.9K

Area of Science:

  • Immunology
  • Neuroscience
  • Oncology

Background:

  • Epstein-Barr virus (EBV) is a human tumor virus linked to lymphomas and carcinomas.
  • Epidemiological studies suggest EBV infection is necessary for developing multiple sclerosis (MS).

Purpose of the Study:

  • To explore how EBV-driven oncogenes may induce B cell differentiation, leading to neuroinflammation in MS.
  • To discuss the role of immune control in the infiltration of T-bet+CXCR3+ B cells into the central nervous system (CNS).

Main Methods:

  • Review of existing epidemiological and immunological studies on EBV, B cells, and MS.
  • Discussion of potential mechanisms of B cell differentiation and CNS infiltration driven by EBV.

Main Results:

  • Insufficient immune control may permit T-bet+CXCR3+ B cells to enter the CNS.
  • These B cells can attract other lymphocytes, stimulate T cells, and differentiate into antibody-producing plasma cells.
  • This process contributes to neuroinflammation and autoantibody production in a subset of MS patients.

Conclusions:

  • EBV-driven B cell populations in the CNS may play a significant role in MS pathogenesis.
  • Targeting these CNS-infiltrating B cells with EBV-specific treatments could be a complementary therapeutic strategy for MS.